Medical weight loss has changed dramatically in the last few years. Modern GLP-1 receptor agonists — most prominently Mounjaro (tirzepatide) and Wegovy (semaglutide) — are showing weight loss results that previously required surgery. For many Wythenshawe residents struggling with weight that won’t shift through diet and exercise alone, these medications are now a clinically supported option.
What are GLP-1 treatments?
GLP-1s mimic a hormone the body naturally produces after meals. They reduce appetite, slow gastric emptying, and improve insulin response. Patients typically eat less because they feel full sooner and stay full longer.
How effective are they?
In clinical trials, patients on tirzepatide (Mounjaro) lost an average of 20–22% of body weight at the highest dose over 72 weeks. Semaglutide (Wegovy) showed averages around 15%. For context, lifestyle-only interventions usually produce 3–5% weight loss.
Who qualifies?
Clinical criteria typically require:
- BMI of 30 or above, OR
- BMI of 27 or above with a weight-related condition (type 2 diabetes, hypertension, sleep apnoea, etc.)
- No contraindications (pregnancy, history of medullary thyroid cancer, MEN2)
What to expect from a Bowland consultation
Your consultation with Ahmed Al-Liabi (Independent Prescriber, GPhC: 2208502) reviews your medical history, current medications, BMI, and weight goals. If clinically suitable, you’ll receive a tailored treatment plan with regular pharmacist follow-ups.
Same-day appointments in Wythenshawe
No GP referral needed. Face-to-face consultations at our Bowland Road clinic. Same-day or next-day slots usually available.
Ready to take the next step?
Book your consultation with Bowland Pharmacy in Wythenshawe. Same-day and next-day appointments usually available.